Rosuvastatin Completed Phase 4 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00747149A Diabetes Study to Treat A Population Previously Not at Target
NCT00262548C-Reactive Protein (CRP) in Obese Diabetic Women